Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice
The paper deals with the treatment policy, including erythropoiesis-stimulating drugs (ESD), in anemic patients with malignancies. The use of ESD remains the basic recommended treatment option for anemia in cancer patients treated with cytostatics if the causes of anemia, which are eliminable by oth...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839574411707940864 |
|---|---|
| author | N. V. Zhukov |
| author_facet | N. V. Zhukov |
| author_sort | N. V. Zhukov |
| collection | DOAJ |
| description | The paper deals with the treatment policy, including erythropoiesis-stimulating drugs (ESD), in anemic patients with malignancies. The use of ESD remains the basic recommended treatment option for anemia in cancer patients treated with cytostatics if the causes of anemia, which are eliminable by other means, are absent. Introduction of darbepoetin α makes ESD therapy more convenient for patients and medical staff. |
| format | Article |
| id | doaj-art-6c44e8dc7c044a0b8406de8ff7ebca3f |
| institution | Matheson Library |
| issn | 1818-8346 2413-4023 |
| language | Russian |
| publishDate | 2022-11-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Онкогематология |
| spelling | doaj-art-6c44e8dc7c044a0b8406de8ff7ebca3f2025-08-04T13:57:52ZrusABV-pressОнкогематология1818-83462413-40232022-11-0103697610.17650/1818-8346-2008-0-3-69-76607Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practiceN. V. Zhukov0Federal Research Clinical Centre of Pediatric Hematology, Oncology and Immunology, Russian Agency for Health CareThe paper deals with the treatment policy, including erythropoiesis-stimulating drugs (ESD), in anemic patients with malignancies. The use of ESD remains the basic recommended treatment option for anemia in cancer patients treated with cytostatics if the causes of anemia, which are eliminable by other means, are absent. Introduction of darbepoetin α makes ESD therapy more convenient for patients and medical staff.https://oncohematology.abvpress.ru/ongm/article/view/729anemiaerythropoiesis-stimulating drugsdarbepoetin α |
| spellingShingle | N. V. Zhukov Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice Онкогематология anemia erythropoiesis-stimulating drugs darbepoetin α |
| title | Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice |
| title_full | Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice |
| title_fullStr | Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice |
| title_full_unstemmed | Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice |
| title_short | Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice |
| title_sort | approaches to treating anemia in patients with malignancies the 2007 2008 changes in russian and international practice |
| topic | anemia erythropoiesis-stimulating drugs darbepoetin α |
| url | https://oncohematology.abvpress.ru/ongm/article/view/729 |
| work_keys_str_mv | AT nvzhukov approachestotreatinganemiainpatientswithmalignanciesthe20072008changesinrussianandinternationalpractice |